ViE Awards shortlist announced! Did you make it?

The nominations have been counted and we are delighted to announce that the shortlist for the 8th Annual ViE Awards has now been chosen. Join us at the World Vaccine Congress on April 7-9 to meet and celebrate with those deemed worthy of these accolades by booking your ticket today.

Hundreds of your colleagues, clients and suppliers voted to choose those who most deserve recognition for their work across 14 categories.

It is an honor to be recognized and gain a place on the shortlist, so well done to those who are below!

As per the tradition for these awards, your vote counts when it comes to picking a winner. As well as asking our anonymous judges to make their choices, your votes will also count towards who wins, therefore vote today. Online voting closes on March 27. 

The 2015 shortlist is:

Best Clinical Trial Network OR Site

  • Benchmark Research
  • Optimal Research
  • PMG Research
  • Heartland Research Associates
  • Miami Research Associates
  • Alliance for Multispecialty Research (AMR)

Best Contract Research Organization

  • Accelovance
  • ICON
  • INC
  • Klifovet
  • Parexel
  • Quintiles

Best Contract Manufacturing Organization

  • Aeras
  • Baxter Biopharma Solutions
  • Fujifilm
  • IDT BIologika
  • Lonza
  • VGXI

Best Technological Development

  • IZON qViro
  • Pall vaccine adjuvant filtration
  • Roche Diagnostics Bio-analytical instrumentation tools
  • Virocyte virus counter 3100

Best Vaccine Partnership / Alliance

  • Greater Gift Initiative
  • GSK/NIH – Ebola vaccine
  • J&J/London School of Hygiene & Tropical Medicine/University of Oxford/Grameen Foundation/Bavarian Nordic/IMI – Ebola Vaccine
  • PfSPZ Malaria Vaccine Clinical Consortium

Best Academic Research Team

  • Duke – program working with Global HIV/AIDS Vaccine Enterprise
  • Harvard Medical School – HIV vaccine program under Dan Barouch
  • Memorial Sloan Ketting Cancer Center – Immunology program under Jedd D. Wolchok
  • University of Pennsylvania – DNA vaccines program under David B. Weiner

Best Financing Deal

  • Advaxis – $23M financing for cancer vaccines (Adage Capital Management, Broadfin Capital, Sectoral Asset Management, Cormorant Asset Management, T. Rowe Price Associates)
  • Anergis – $15 million to take allergy vaccine to Phase III (Sunstone Capital, BioMedInvest and Renaissance PME and WJFS, Inc)
  • Immatics – $30M for cancer vaccine trial (Series D funding from dievini Hopp Biotech holding, Wellington Partners, AT Impf GmbH and others)
  • Vaxxas – $20M to develop needle-free vaccines (OneVentures with co-investors Brandon Capital, the Medical Research Commercialisation Fund (MRCF), and US-based HealthCare Ventures.)

Best Vaccine Licence

  • Aduro and J&J licencing agreement for novel immunotherapies for prostate cancer
  • Immunomics licencing deal with Astellas for allergy vaccines
  • NewLink and Merck Ebola vaccine licensing agreement
  • Phibro Animal Health Corporation licensing agreement with Merial for vaccine delivery technology

Best Early-Stage Biotech

  • Advaxis
  • Amgen
  • EpiVax
  • Inovio
  • Vivaldi Biosciences

Best Biotech CEO

  • Stan Erck, Novavax
  • Annie de Groot, EpiVax
  • Stephen Hoffman, Sanaria
  • Stephen Isaacs, Aduro Biotech
  • Daniel J. O’Connor, Advaxis

Best Pharma Company

  • GSK
  • J&J
  • Medimmune
  • Merck & Co
  • Pfizer
  • Sanofi Pasteur

Best Prophylactic Vaccine (approved or in development)

  • GSK – RTS,S AS01 for Malaria
  • J&J/London School of Hygiene & Tropical Medicine/University of Oxford/Grameen Foundation/Bavarian Nordic/IMI – AdVac Ebola Vaccine
  • Newlink and Merck – SV-EBOV for Ebola
  • Pfizer – TRUMENBA for MenB
  • Sanaria – PfSPZ for Malaria
  • Sanofi Pasteur – YF-VAX for Dengue

Best Therapeutic Vaccine (approved or in development)

  • Advaxis – HER2 for osteosarcoma
  • Oncosec – IL-12 Immunopulse
  • Inovio – VGX-3100 DNA vaccine
  • Agenus – Prophage for brain cancer
  • Aduro BioTech – GVAX for pancreatic cancer

The Outstanding Achievement Award will be chosen by our judges and revealed only on the night.

Those listed above are the leading lights in the vaccine sector, to ensure you have a chance to network with them and make connections that could change your business, book your ticket to the World Vaccine Congress today. Don’t forget to submit your vote!

Take a look at the full agenda and list of over 450 confirmed attendees.

Well done to all of those who have made the shortlist, we look forward to celebrating with you all at the 8th Annual ViE Awards on Wednesday April 8! 

Leave a Reply

Your email address will not be published. Required fields are marked *